Drug Pipeline

Gamma-glutamylcysteine (GGC) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT07583251
Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI…		 Recruitment opened
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07064005 Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's… Parkinsons Disease (PD) Recruiting
NCT07050173 Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine… Repetitive Head Impacts Recruiting
NCT07583251 Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI… Mild Cognitive Impairment (MCI) Recruiting
Sponsors Running Gamma-glutamylcysteine (GGC) Trials
Pravat Mandal (3)
Disease Areas
Parkinson's Disease (1)
Get alerts when Gamma-glutamylcysteine (GGC) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free